Sorrento Therapeutics (SRNE) Stock Chart & Stock Price History $0.0013 0.00 (-18.75%) As of 05/23/2025 03:32 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock Sorrento Therapeutics Stock Price Performance The Sorrento Therapeutics (SRNE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 85.56%, with a year-to-date return of 160.00%. In the past month, the stock has decreased 68.29%, reflecting recent market activity. As of the latest close, Sorrento Therapeutics traded at $0.00 with a market cap of $717,000.00 and volume of 121,207 shares. Five years ago, the stock traded at $5.07, representing a 99.97% decrease over that period. At the time, it had a market cap of $1.20 billion and a volume of 48.07 million shares. Receive SRNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-38.10%1 Month Performance-68.29%3 Month Performance+116.67%Year-To-Date Performance+160.00%1 Year Performance-85.56%5 Year Performance-99.97% SRNE Stock Chart for Saturday, May, 24, 2025 SRNE Chart by TradingView Sorrento Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$0.00$0.00-18.75%$0.00$0.00121,207 shs$717,000.0005/22/2025$0.01$0.00-76.12%$0.00$0.00272,778 shs$882,000.0005/21/2025$0.00$0.01+509.09%$0.01$0.0014,903 shs$3.69 million05/20/2025$0.00$0.00-47.62%$0.00$0.00126,639 shs$606,000.0005/19/2025$0.00$0.00+90.91%$0.00$0.00251,326 shs$1.16 million05/16/2025$0.00$0.00-8.33%$0.00$0.0031,206 shs$606,000.0005/15/2025$0.01$0.00-82.09%$0.01$0.00167,794 shs$662,000.0005/14/2025$0.00$0.01+509.09%$0.01$0.0033,718 shs$3.69 million05/13/2025$0.00$0.00-47.62%$0.00$0.0067,645 shs$606,000.0005/12/2025$0.00$0.00$0.00$0.00663,892 shs$1.16 million Get the Latest News and Ratings for SRNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025$0.00$0.00+61.54%$0.00$0.005,427 shs$1.16 million05/08/2025$0.00$0.00+44.44%$0.00$0.0032,027 shs$717,000.0005/07/2025$0.00$0.00$0.00$0.009,726 shs$496,000.0005/06/2025$0.00$0.00$0.00$0.0034,732 shs$496,000.0005/05/2025$0.00$0.00$0.00$0.0096,975 shs$496,000.0005/02/2025$0.00$0.00$0.00$0.00296,260 shs$496,000.0005/01/2025$0.00$0.00$0.00$0.0092,091 shs$496,000.0004/30/2025$0.00$0.00$0.00$0.0062,794 shs$496,000.0004/29/2025$0.00$0.00$0.00$0.00183,772 shs$496,000.0004/28/2025$0.00$0.00-10.00%$0.00$0.0057,221 shs$496,000.0004/25/2025$0.00$0.00-75.61%$0.00$0.0047,780 shs$551,000.0004/24/2025$0.00$0.00+355.56%$0.00$0.00169,790 shs$2.26 million04/23/2025$0.00$0.00-10.00%$0.00$0.0035,350 shs$496,000.00 Related Companies Clearmind Medicine Stock Chart Alaunos Therapeutics Stock Chart Conduit Pharmaceuticals Stock Chart Oragenics Stock Chart Sonnet BioTherapeutics Stock Chart Galecto Stock Chart Titan Pharmaceuticals Stock Chart Sunshine Biopharma Stock Chart Jaguar Health Stock Chart Matinas Biopharma Stock Chart Receive SRNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SRNE) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sorrento Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRNE Stock Free SRNE Stock Alerts